Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-21 | New | $34,748,596 | Unknown | Equity Only | SEC link | |
| 2025-02-26 | New | $2,780,366 | $2,780,366 | Debt Only | 06b | SEC link |
| 2022-08-17 | New | $15,410,669 | $15,410,669 | Equity Only | 06b | SEC link |
| 2020-10-26 | New | $5,223,426 | $5,223,426 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Stephen Bloch | Director |
| Andrew Corley | Director |
| Michael Haydin | Executive |
| Michael George Haydin, Iv | Executive |
| Tsontcho Ianchulev | Director, Executive |
| Marc Andre Marcotte | Director |
| James Mazzo | Director |
| Todd Sone | Director |
| Adam Szaronos | Director, Executive |
| Casey Tansey | Director |
| Farrell Tyson | Director |
| Jeffry K. Weinhuff | Director |
| Jeffrey K. Weinhuff | Director |
| Robert Weinreb | Director |